Diagnostic Imaging - Global Strategic Business Report

The global market for Diagnostic Imaging is estimated at US$29.0 Billion in 2023 and is projected to reach US$41.0 Billion by 2030, growing at a CAGR of 5.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the diagnostic imaging market is driven by several factors, including the aging global population, the rising prevalence of chronic diseases, technological advancements in imaging modalities, and increasing healthcare expenditure. As the population ages, there is a higher incidence of conditions such as cardiovascular diseases, cancers, and neurological disorders, all of which require diagnostic imaging for effective management. Chronic diseases are also becoming more common across all age groups, necessitating frequent monitoring and evaluation, which supports the demand for imaging services. Technological advancements not only enhance the quality and efficiency of diagnostic imaging but also expand its applications, leading to broader clinical adoption. Additionally, healthcare systems worldwide are focusing more on preventive care and early diagnosis, which further drives the demand for advanced imaging solutions. The increasing investment in healthcare infrastructure, especially in emerging economies, and the growing acceptance of hybrid and advanced imaging modalities contribute to the robust growth of this market. Thus, diagnostic imaging continues to be an indispensable part of modern medical practice, with ongoing innovations ensuring its expanding role in healthcare delivery.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the X-ray Imaging segment, which is expected to reach US$9.4 Billion by 2030 with a CAGR of a 4.5%. The MRI segment is also set to grow at 5.4% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $8.8 Billion in 2023, and China, forecasted to grow at an impressive 7.2% CAGR to reach $5.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Diagnostic Imaging Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Diagnostic Imaging Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Diagnostic Imaging Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Barco NV, Agfa-Gevaert NV, Analogic Corporation, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 66 Featured):

• Barco NV
• Agfa-Gevaert NV
• Analogic Corporation
• Brainlab AG
• Adelaide Health Care
• Bracco Diagnostics, Inc.
• Accuray, Inc.
• Bracco SpA
• Biodex Medical Systems, Inc.
• Brain Scientific Inc.
• Alliance Medical Limited
• Asahi Roentgen Ind. Co., Ltd.
• A. Menarini Asia-Pacific Holdings Pte., Ltd.
• Beijing Wandong Medical Technology Co., Ltd.
• Bonraybio Company Limited